Glaxosmithkline - GLAXO
Rs 137.26
Change 1.01
On May 17
Trades end of day
| Last trade on | May 17, 2024 | Day's range | Rs 135.00 - 138.20 |
|---|---|---|---|
| Change | Rs 1.01 | 52 week range | Rs 68.00 - 141.50 |
| Open | Rs 136.25 | Volume | 138,000 |
| Close | Rs 137.26 | Previous Close | Rs 137.26 |
GLAXO Trade Activity
| Period | High | Low | Volume |
|---|---|---|---|
| 1M | 137.26 | 91.50 | 6,037,000.00; Avg 301,850.00 |
| 3M | 137.26 | 79.00 | 10,986,000.00; Avg 183,100.00 |
| 6M | 137.26 | 77.20 | 19,837,000.00; Avg 162,598.00 |
| 1Y | 137.26 | 68.06 | 25,231,400.00; Avg 102,566.00 |
Latest Annual Financials
| Financial Year | 2022 | O/S Shares | 318.47m |
|---|---|---|---|
| Net Profit | Rs 2,462.89m | Market Cap | Rs 43,712.81m |
| EPS | 7.73 | P/E | 17.75 |
| Par | Rs 10.00 | Net Worth | Rs 12,038.66m |
| Dividend | Rs 0.00 | Dividend Yield | 0.00 |
| Right | 0.00 | Long Term Debt | 1,580.23 |
| Fixed Assets | 12,038.66m | Net Sales | 41,841.58m |
| Share High | 126.71 | Retained Earnings | 17,686.44m |
| Premium | Rs 0.00 | Bonus | 0.00% |
| Paid up Capital | 3,184.67m | Working Capital | 10,597.68m |
| Share Low | Rs 74.02 | Price at BOD Meeting | Rs 90.90 |
| Share Average | Rs 100.36 | Depreciation | 805.69m |
| Export Sales | 26.46m | Financial Expense | 716.26m |
The company is in the Pharmaceuticals sector.
Other Companies in This Sector
| Company | Current | Change | Date |
|---|---|---|---|
| Abbot Laboratories | Rs 669.26 | 1.20% | May 17, 2024 |
| AGP Limited | Rs 91.31 | -0.75% | May 17, 2024 |
| Citi Pharma Limited | Rs 31.89 | -0.03% | May 17, 2024 |
| Ferozsons Laboratories Limited | Rs 252.67 | -0.52% | May 17, 2024 |
| Glaxosmithkline | Rs 137.26 | 0.74% | May 17, 2024 |
| Glaxo Healthcare Pakistan | Rs 120.23 | -3.20% | Jan 30, 2023 |
| Haleon Pakistan Limited | Rs 264.86 | 5.10% | May 17, 2024 |
| Highnoon Laboratories | Rs 678.99 | 0.09% | May 17, 2024 |
| Hoechst Pakistan Limited | Rs 1,526.97 | 3.52% | May 17, 2024 |
| IBL Healthcare Limited | Rs 34.48 | 1.11% | May 17, 2024 |
| IBL Healthcare Limited (r) | Rs 0.00 | 0.00% | May 18, 2024 |
| Macter International Limited | Rs 89.85 | -0.04% | May 16, 2024 |
| Macter International Limited (r) | Rs 0.00 | 0.00% | May 18, 2024 |
| Otsuka Pakistan Limited | Rs 129.39 | 1.24% | May 17, 2024 |
| Sanofi-aventis Pharmaceutical Pakistan Limited | Rs 870.00 | 0.00% | Oct 27, 2023 |
Shareholding Pattern
| Year | Individual | Institutions | Investment Companies | Foreign Investors | Government | Shareholders | Other |
|---|---|---|---|---|---|---|---|
| 2022 | 5.98% | 3.67% | 82.59% | 0.17% | 0.00% | 7,063.00 | 4.32% |
| 2021 | 6.04% | 3.20% | 82.59% | 0.18% | 0.00% | 7,199.00 | 4.79% |
| 2020 | 5.96% | 3.55% | 82.59% | 0.19% | 0.00% | 6,970.00 | 0.94% |
| 2019 | 6.73% | 6.76% | 82.59% | 0.06% | 0.00% | 7,819.00 | 0.00% |
| 2018 | 6.62% | 6.12% | 82.59% | 0.26% | 0.00% | 8,017.00 | 4.41% |
| 2017 | 1.26% | 16.14% | 82.59% | 0.00% | 0.00% | 8,409.00 | 0.01% |
| 2016 | 1.32% | 16.07% | 82.59% | 0.00% | 0.00% | 7,536.00 | 0.01% |
| 2015 | 1.47% | 0.00% | 15.92% | 82.59% | 0.00% | 7,152.00 | 0.01% |
| 2014 | 1.53% | 0.00% | 15.87% | 82.59% | 0.00% | 6,958.00 | 0.01% |
| 2013 | 1.65% | 0.00% | 15.75% | 82.59% | 0.00% | 5,981.00 | 0.01% |
| 2012 | 1.84% | 0.00% | 15.56% | 82.59% | 0.00% | 5,546.00 | 0.01% |
| 2011 | 1.94% | 0.00% | 15.46% | 82.59% | 0.00% | 4,836.00 | 0.01% |
| 2010 | 2.23% | 0.00% | 16.19% | 81.56% | 0.00% | 4,876.00 | 0.02% |
| 2009 | 2.73% | 0.00% | 18.47% | 78.78% | 0.00% | 4,822.00 | 0.02% |
| 2008 | 2.83% | 0.00% | 18.37% | 78.78% | 0.00% | 4,503.00 | 0.02% |
| 2007 | 3.02% | 0.01% | 18.17% | 78.78% | 0.00% | 4,434.00 | 0.02% |
| 2006 | 3.32% | 0.05% | 17.83% | 78.78% | 0.00% | 4,271.00 | 0.02% |
| 2005 | 3.95% | 0.05% | 17.20% | 78.78% | 0.00% | 3,956.00 | 0.02% |
| 2004 | 4.41% | 0.05% | 16.74% | 78.78% | 0.00% | 3,661.00 | 0.02% |
| 2003 | 4.83% | 0.09% | 16.27% | 78.78% | 0.00% | 3,467.00 | 0.03% |
| 2002 | 5.42% | 0.38% | 15.35% | 78.78% | 0.00% | 3,822.00 | 0.07% |